NFSG
CLPT icon

Newbridge Financial Services Group’s ClearPoint Neuro CLPT Stock Holding History

Newbridge Financial Services Group’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9 Hold
1
– – ﹤0.01% 1172
2025
Q4 		$14 Hold
1
– – ﹤0.01% 1168
2025
Q3 		$22 Hold
1
– – ﹤0.01% 1275
2025
Q2 		$12 Hold
1
– – ﹤0.01% 1307
2025
Q1 		$12 Hold
1
– – ﹤0.01% 1036
2024
Q4 		$15 Buy
+1
New +$13 ﹤0.01% 1130

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Newbridge Financial Services Group's CLPT Position: Q1 2026 in Review

Newbridge Financial Services Group held its ClearPoint Neuro (CLPT) position steady in Q1 2026 at 1 share worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Newbridge Financial Services Group first reported a position in CLPT in Q4 2024 and has held it in 6 quarters since. The position peaked at $22 in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Newbridge Financial Services Group held 1 share of ClearPoint Neuro worth $9 as of Q1 2026.
  • Newbridge Financial Services Group left its ClearPoint Neuro share count unchanged in Q1 2026.
  • ClearPoint Neuro made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #1172 holding.
  • Newbridge Financial Services Group first reported a position in ClearPoint Neuro in Q4 2024 and has held it in 6 quarters since.
  • Newbridge Financial Services Group's ClearPoint Neuro position peaked at $22 in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.